Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (501-510 of 642) with videos related to

Pageof 65
Sort By:
Circulation. Cardiovascular Imaging|October 8, 2009
Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expressionMariann Gyöngyösi, Jeronimo Blanco, Teréz Marian, et al.
Heart and Vessels|March 16, 2013
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitorsGiuseppe De Luca, Arnoud W J van't Hof, Kurt Huber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 25, 2012
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperationGiuseppe De Luca, C Michael Gibson, Kurt Huber, et al.
European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Stress-induced cardiomyopathy (Tako-Tsubo syndrome) in AustriaValerie Weihs, Daniela Szücs, Barbara Fellner, et al.
Clinical Chemistry|May 19, 2017
Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary SyndromeMark Y Chan, Megan L Neely, Matthew T Roe, et al.
American Heart Journal|December 5, 2009
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trialJeffrey S Berger, Matthew T Roe, C Michael Gibson, et al.
Cardiovascular Research|September 23, 2003
Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytesThomas W Weiss, Walter S Speidl, Christoph Kaun, et al.
The American Journal of Cardiology|September 10, 2013
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)Jean-Philippe Collet, Kurt Huber, Marc Cohen, et al.
European Heart Journal. Acute Cardiovascular Care|September 9, 2025
Reperfusion therapy for ST elevation myocardial infarction in low- to middle-income countries: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the European Association of Preventive Cardiology (EAPC), the ESC Working Group on Thrombosis, and the Stent - Save a Life! InitiativeDiego Araiza-Garaygordobil, Thomas Alexander, Kurt Huber, et al.
Haematologica|January 25, 2020
Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesiclesPhilipp J Hohensinner, Julia Mayer, Julia Kichbacher, et al.
Pageof 65

Showing results (501-510 of 642) with videos related to

Sort By:
Pageof 65
Circulation. Cardiovascular Imaging|October 8, 2009
Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expressionMariann Gyöngyösi, Jeronimo Blanco, Teréz Marian, et al.
Heart and Vessels|March 16, 2013
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitorsGiuseppe De Luca, Arnoud W J van't Hof, Kurt Huber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 25, 2012
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperationGiuseppe De Luca, C Michael Gibson, Kurt Huber, et al.
European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Stress-induced cardiomyopathy (Tako-Tsubo syndrome) in AustriaValerie Weihs, Daniela Szücs, Barbara Fellner, et al.
Clinical Chemistry|May 19, 2017
Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary SyndromeMark Y Chan, Megan L Neely, Matthew T Roe, et al.
American Heart Journal|December 5, 2009
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trialJeffrey S Berger, Matthew T Roe, C Michael Gibson, et al.
Cardiovascular Research|September 23, 2003
Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytesThomas W Weiss, Walter S Speidl, Christoph Kaun, et al.
The American Journal of Cardiology|September 10, 2013
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)Jean-Philippe Collet, Kurt Huber, Marc Cohen, et al.
European Heart Journal. Acute Cardiovascular Care|September 9, 2025
Reperfusion therapy for ST elevation myocardial infarction in low- to middle-income countries: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the European Association of Preventive Cardiology (EAPC), the ESC Working Group on Thrombosis, and the Stent - Save a Life! InitiativeDiego Araiza-Garaygordobil, Thomas Alexander, Kurt Huber, et al.
Haematologica|January 25, 2020
Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesiclesPhilipp J Hohensinner, Julia Mayer, Julia Kichbacher, et al.
Pageof 65